Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04266301
Title Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) (STIMULUS-MDS2)
Acronym STIMULUS-MDS2
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
Yuma Regional Cancer Center Yuma Arizona 85364 United States Details
University Of California LA . Los Angeles California 90095 United States Details
Yale University School Of Medicine Smilow Cancer Hospital New Haven Connecticut 06520 United States Details
Mayo Clinic Jacksonville . Jacksonville Florida 32224 United States Details
University Of Miami . Miami Florida 33136 United States Details
Northwestern University Div of Hematology/Oncology Chicago Illinois 60611 United States Details
Massachusetts General Hospital . Boston Massachusetts 02114 United States Details
Hackensack University Medical Ctr SC Hackensack New Jersey 07601 United States Details
Weill Cornell Medicine NY-Presb . New York New York 10021 United States Details
University of Rochester Medical Ctr Dept.ofUniv.Rochester/JPWilmot Rochester New York 14642 United States Details
University of Virginia University of Virginia Charlottesville Virginia 22903 United States Details
Novartis Investigative Site Pilar Buenos Aires B1629AHJ Argentina Details
Novartis Investigative Site Woolloongabba Queensland 4102 Australia Details
Novartis Investigative Site Clayton Victoria 3168 Australia Details
Novartis Investigative Site Perth Western Australia 6000 Australia Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Innsbruck A-6020 Austria Details
Novartis Investigative Site Linz A-4010 Austria Details
Novartis Investigative Site Brasschaat 2930 Belgium Details
Novartis Investigative Site Roeselare 8800 Belgium Details
Novartis Investigative Site Florianopolis SC 88034-000 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Sao Paulo SP 05319-000 Brazil Details
Novartis Investigative Site Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Vina del Mar Valparaiso 2540364 Chile Details
Novartis Investigative Site Guangzhou Guangdong 51000 China Details
Novartis Investigative Site Guangzhou Guangdong 510515 China Details
Novartis Investigative Site Shenzhen Guangdong 518037 China Details
Novartis Investigative Site Wuhan Hubei 430022 China Details
Novartis Investigative Site Wuhan Hubei 430030 China Details
Novartis Investigative Site Suzhou Jiangsu 215006 China Details
Novartis Investigative Site Chang Chun Jilin 130021 China Details
Novartis Investigative Site Hangzhou Zhejiang 310003 China Details
Novartis Investigative Site Beijing 100029 China Details
Novartis Investigative Site Beijing 100730 China Details
Novartis Investigative Site Chengdu 610041 China Details
Novartis Investigative Site Jinan 250012 China Details
Novartis Investigative Site Shanghai 200025 China Details
Novartis Investigative Site Shanghai 200233 China Details
Novartis Investigative Site Tianjin 300020 China Details
Novartis Investigative Site Tianjin 300052 China Details
Novartis Investigative Site Rionegro Antioquia 054047 Colombia Details
Novartis Investigative Site Bogota 110231 Colombia Details
Novartis Investigative Site Praha 2 Czech Republic 128 20 Czechia Details
Novartis Investigative Site Hradec Kralove CZE 500 05 Czechia Details
Novartis Investigative Site Brno - Bohunice 625 00 Czechia Details
Novartis Investigative Site Praha 12808 Czechia Details
Novartis Investigative Site Helsinki FIN 00290 Finland Details
Novartis Investigative Site Kuopio 70211 Finland Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Paris 10 75475 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Tours 37044 France Details
Novartis Investigative Site Vandoeuvre Les Nancy 54511 France Details
Novartis Investigative Site Velbert North Rhine-Westphalia 42551 Germany Details
Novartis Investigative Site Dresden Sachsen 01307 Germany Details
Novartis Investigative Site Augsburg 86179 Germany Details
Novartis Investigative Site Duesseldorf 40479 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Greifswald 17475 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Kiel 24116 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Alexandroupolis Evros 681 00 Greece Details
Novartis Investigative Site Patras 265 00 Greece Details
Novartis Investigative Site Ahmedabad Gujrat 380009 India Details
Novartis Investigative Site Faridabad Haryana 121 001 India Details
Novartis Investigative Site Madurai Tamil NADU 625107 India Details
Novartis Investigative Site Kolkata West Bengal 700014 India Details
Novartis Investigative Site Kolkata West Bengal 700160 India Details
Novartis Investigative Site Delhi 110 085 India Details
Novartis Investigative Site Afula 1834111 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Catania CT 95123 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00133 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Sapporo Hokkaido 064 0804 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Sendai city Miyagi 980 8574 Japan Details
Novartis Investigative Site Nagasaki-city Nagasaki 852-8501 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8603 Japan Details
Novartis Investigative Site Osaka 545-8586 Japan Details
Novartis Investigative Site Yamagata 990 9585 Japan Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Beirut 1107 2020 Lebanon Details
Novartis Investigative Site Vilnius LT-08661 Lithuania Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Pulau Pinang 10990 Malaysia Details
Novartis Investigative Site Selangor 68000 Malaysia Details
Novartis Investigative Site Mexico Distrito Federal 06726 Mexico Details
Novartis Investigative Site Satelite Edo Mexico 53100 Mexico Details
Novartis Investigative Site Morelia Michoacan 58260 Mexico Details
Novartis Investigative Site Estado de Mexico 52787 Mexico Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Muscat 123 Oman Details
Novartis Investigative Site Lisboa 1099 023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Saint Petersburg 197022 Russian Federation Details
Novartis Investigative Site St Petersburg 191024 Russian Federation Details
Novartis Investigative Site Riyadh 11211 Saudi Arabia Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Oviedo Asturias 33011 Spain Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Bern 3010 Switzerland Details
Novartis Investigative Site Zürich 8091 Switzerland Details
Novartis Investigative Site Hualien City Hualien 970 Taiwan Details
Novartis Investigative Site Kaohsiung 83301 Taiwan Details
Novartis Investigative Site Liouying Township 736005 Taiwan Details
Novartis Investigative Site Taichung 40447 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Khon Kaen THA 40002 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Chiang Mai 50200 Thailand Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Edirne 22030 Turkey Details
Novartis Investigative Site Istanbul 34890 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
Novartis Investigative Site Samsun 55139 Turkey Details
Novartis Investigative Site Portsmouth Hants PO6 3LY United Kingdom Details
Novartis Investigative Site Edinburgh EH4 2XU United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field